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Abstract
Background: Bartonella henselae (B. henselae) is considered a rare cause of granulomatous hepatitis. Due to the
fastidious growth characteristics of the bacteria, the limited sensitivity of histopathological stains, and the non-
specific histological findings on liver biopsy, the diagnosis of hepatic bartonellosis can be difficult to establish.
Furthermore, the optimal treatment of established hepatic bartonellosis remains controversial.
Case presentation: We present a case of hepatic bartonellosis in an immunocompetent woman who presented
with right upper quadrant pain and a five cm right hepatic lobe mass on CT scan. The patient underwent a right
hepatic lobectomy. Surgical pathology revealed florid necrotizing granulomatous hepatitis, favoring an infectious
etiology. Despite extensive histological and serological evaluation a definitive diagnosis was not established initially.
Thirteen months after initial presentation, hepatic bartonellosis was diagnosed by PCR studies from surgically
excised liver tissue. Interestingly, the hepatic granulomas persisted and Bartonella henselae was isolated from the
patient’s enriched blood culture after several courses of antibiotic therapy.
Conclusion: The diagnosis of hepatic bartonellosis is exceedingly difficult to establish and requires a high degree
of clinical suspicion. Recently developed, PCR-based approaches may be required in select patients to make the
diagnosis. The optimal antimicrobial therapy for hepatic bartonellosis has not been established, and close follow-up
is needed to ensure successful eradication of the infection.
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Background
Cat scratch disease (CSD) is caused by B. henselae,a
gram-negative, aerobic alpha Proteobacterium that is
transmitted by the bite or scratch of a cat. The traditional
diagnostic criteria for CSD include (1) contact with a cat
and history of a scratch or other inoculation event, (2)
positive cat scratch skin test reaction, (3) regional lympha-
denopathy with no other apparent etiology, and (4) char-
acteristic histopathologic features on biopsy [1]. The
development of PCR-based diagnostic assays has revealed
a growing number of cases in which the traditional diag-
nostic criteria for CSD were absent [2].
Hepatic bartonellosis has been reported in 1-2% of
CSD cases, and represents the third most common
clinical manifestation after fever and lymphadenopathy.
The typical symptoms include right upper quadrant pain,
fevers, malaise, weight loss, chills and headaches [3].
Establishing the diagnosis of CSD-induced liver dis-
ease can be challenging:
Radiologic evaluation by contrast-enhanced CT may
show a range of abnormalities, with lesions that are
hypoattenuating, iso-attenuating, or show rim enhance-
ment relative to the uninvolved liver [4]. MRI imaging
may show suggestive imaging patterns of the granulomas
[5].
Histologically, hepatic bartonellosis is characterized by
the presence of necrotizing granulomas. They are caused
by the focal accumulation of activated macrophages,
with a surrounding rim of lymphocytes and fibroblasts.
However, hepatic granulomas are nonspecific and may
be associated with a variety of liver diseases [6]. Steiner
silver staining, Bartonella-specific immunohistochemical
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dies [7] have been shown to have diagnostic utility but
may be less sensitive and specific compared to PCR test-
ing [8-12]. PCR assays do not rely on the presence of a
humoral immune response, and may therefore be diag-
nostic at an earlier stage of infection, or during chronic
infection in anergic patients.
Conventional bacterial cultures of liver tissue are rarely
diagnostic of B. henselae hepatitis. However, Breitschwerdt
and colleagues have recently developed an optimized
enrichment culture method that enhances diagnostic
detection and molecular typing (by DNA sequencing of
the PCR amplicon) of B. henselae and other Bartonella
spp. from venous blood. This highly sensitive method is
able to detect active infection in patients who lack B. hen-
selae antibodies and in whom conventional bacterial
cultures have been negative [13,14].
In this study, we describe how the use of optimized
serum and tissue PCR assays resulted in the establishment
of B. henselae hepatitis in a young, immunocompetent
patient with severe granulomatous hepatitis.
Case presentation
In August, 2008, a 36 year-old woman with no prior his-
tory of liver disease presented to her primary care physi-
cian complaining of abdominal pain of five days duration.
The pain was constant, sharp, localized to the right upper
quadrant, non-radiating, and associated with nausea but
no vomiting. Review of systems was positive for fatigue.
Initial laboratory testing revealed only a mildly elevated
alanine aminotransferase (ALT) of 42 IU/L. A right upper
quadrant ultrasound demonstrated hepatomegaly and
steatosis. Two weeks later, the patient presented to an out-
side hospital with worsening right upper quadrant pain,
low-grade fevers, nausea and vomiting. An MRI of the
abdomen revealed a two cm enhancing lesions of the right
hepatic lobe. Fine needle biopsy of the lesion demon-
strated a nonspecific, mixed inflammatory cellular infil-
trate and steatohepatitis. There was no evidence of
malignancy. Fungal and mycobacterial cultures were nega-
tive. The patient was discharged without a specific diagno-
sis, and no treatment was instituted.
Two months later, the patient presented to Loyola Uni-
versity Medical Center with worsening right upper quad-
rant pain and fever. An abdominal CT scan revealed a 4.8
× 4.7 cm mass lesion involving the right hepatic lobe that
was suspicious for malignancy (Figure 1). The patient
underwent a partial right hepatectomy with excision of the
mass. Histopathological studies of the resection specimen
showed florid necrotizing granulomatous inflammation
with pseudotumor formation (Figure 2, 3). Immuno-histo-
chemical stains for mycobacteria, fungal organisms, and
cytomegalovirus were negative. The patient’sp r e s e n t i n g
symptoms resolved, and she was discharged home after an
uneventful postoperative recovery.
In April of 2009, the right upper quadrant pain and
low-grade fevers recurred. The patient presented to an
outside hospital where an extensive evaluation was
initiated (Table 1). Serologies for acute viral hepatitis
were negative. Qualitative antibodies for toxoplasmosis,
human immunodeficiency virus, and Entamoeba histoly-
tica were negative. An EIA for Borrelia burgdorferi anti-
bodies was negative. IFA assays for Bartonella henselae
and Bartonella quintana were negative. Testing for urin-
ary histoplasmosis and blastomycosis antigens and
Figure 1 Abdominal CT image demonstrating a large mass
lesion in the right hepatic lobe.
Figure 2 The right partial hepatectomy shows florid
necrotizing granulomatous inflammation for a peudotumorous
mass (Figure 2, hematoxylin and eosin 100×). Necrotizing
granulomatous inflammation with giant cells and characteristic
palisading histiocytes.
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for tuberculosis and quantiferon gold were negative. A
random liver biopsy showed mild macro- and micro-
vesicular steatosis and non-specific chronic inflamma-
tion. Repeat special stains, fungal and mycobacterial
cultures were negative. The patient’ss y m p t o m s
improved, and she was discharged home on analgesics.
In July of 2009, the patient once again presented to an
outside hospital with right upper quadrant pain, nausea,
and fevers of up to 102.
4°F. An abdominal CT revealed
several low attenuation lesions involving both segments
of the liver, with the largest one measuring 4.1 × 2.9 cm
(Figure 4). The patient was transferred to Loyola Uni-
versity Medical Center for further evaluation. A detailed
travel and exposure history to ticks, rodents or other
vectors of unusual infectious etiologies was unrevealing.
On physical examination, the patient was afebrile. There
was no lymphadenopathy or hepato-splenomegaly. Her
right upper quadrant was tender to palpation without
rebound tenderness or guarding. Laboratory analysis
revealed an aspartate aminotransferase (AST) of 93 IU/L
UNITS, alanine aminotransferase (ALT) of 74 IU/L,
alkaline phosphatase of 193 IU/L, and total bilirubin of
0.6 mg/dL. The hemoglobin was 13.4 gm/dL, and the
WBC count was 4.9 K/UL with a normal differential.
Bacterial blood cultures, urinalysis, stool cultures, and
stool tests for Clostridium difficile were negative. A
chest radiograph showed no infiltrates or lymphadeno-
pathy. The antinuclear antibody was 1:40, and anti-mito-
chondrial antibody testing was negative.
On the third day of her hospitalization, the patient
developed a temperature of 101.
1°F. A comprehensive
Figure 3 The right partial hepatectomy shows florid necrotizing
granulomatous inflammation for a peudotumorous mass.
Necrotizing granulomatous inflammation with giant cells and
characteristic palisading histiocytes (Figure 3, hematoxylin and eosin
400×).
Table 1 Serological tests performed to identify the etiology of granulomatous hepatitis in the patient
Test Reference Range Result Admission 1 Result Admission 2
Antibody to human immunodeficiency virus Negative Negative Negative
Quatiferon Gold Negative Negative
Epstein Barr virus
IgM Negative Negative
IgG Negative Positive
Bartonella Antibody
B. quintana-IgM, IgG Negative at 1:20, 1:60 dilution Negative Negative
B. hensalae Negative
Lyme Antibody Negative Negative
Toxoplasma
IgM Negative Negative
IgG Negative Negative
Rapid plasma reagin Negative Negative
Entamoeba Antibody Negative Negative
Coxiella bruniti (ELISA) Negative Negative
Brucella Antibody
IgM Negative at 1:20 dilution Negative
IgG Negative at 1:60 dilution Negative
Cyrptococcal Ag (serum) Negative Negative
Histoplasma Ag (urinary) Negative Negative
Blastomycosis Ag (urinary) Negative Negative
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(see Table 1). Antibody titers for Bartonella quintana,
and Brucella sp. were negative. An RPR was negative.
Repeat HIV antibody testing was negative. A peripheral
smear for malaria was negative. A transesophageal echo-
cardiogram did not reveal any valvular vegetations. The
patient refused a lumbar puncture. A percutaneous liver
biopsy was performed and revealed extensive granulo-
matous hepatitis with occasional fibrin rings, with a
background of mixed, micro- and macro-vesicular stea-
tosis. Based on the presence of fibrin rings, the possibi-
lity of Q fever was entertained. However, ELISA testing
for Coxiella burnetti antibodies was negative. Repeat
special stains and cultures for AFB, fungal organisms,
and cytomegalovirus were negative. Steiner silver stains
for spirochetes and bacteria - including Bartonella sp.-
were negative. The patient was empirically treated with
a seven-day course of piperacillin and tazobactam. She
remained afebrile for the remainder of her hospitaliza-
tion. Based on the diagnosis of granulomatous hepatitis
and the unrevealing workup for infectious organisms,
the patient was started on empiric prednisone. Her liver
enzymes, which had already been down-trending at the
start of prednisone treatment, normalized over the next
several weeks. Her symptoms resolved, and she was dis-
charged home on a tapering dose of prednisone.
Based on the striking features of her hepatic granulomas,
the possibility of hepatic Bartonella infection was raised,
despite the negative Bartonella antibody titers. A sample
of formalin-fixed liver tissue from the initial liver resection
was sent to the University of Arkansas for PCR testing.
Using previously validated assay conditions, a 153 bp
fragment of the B. henselae 16S rRNA gene was amplified,
and confirmed by Southern blot hybridization [15,16].
Upon further questioning, the patient reported that she
had intermittently come in contact with a cat while visit-
ing her mother’s house, although she did not recall any cat
scratches or bites.
Based on the presumptive diagnosis of hepatic barto-
nellosis, the patient was started on azithromycin 250 mg
daily, and her prednisone was discontinued. Two weeks
later, the patient develop e dd i a r r h e aa n da b d o m i n a l
cramping that were attributed to her antibiotic. Azithro-
mycin was discontinued, and the patient was started on
a nine-week course of clarithromycin at a dose of 500
mg twice daily. Her symptoms completely resolved.
In May of 2010, the patient presented to our emergency
room with recurrent right upper quadrant pain. On exam-
ination, she was afebrile and her vital signs were stable.
There was no jaundice. Right upper quadrant tenderness
was present in the area of the excisional scar. There was
no palpable hepato-splenomegaly. No skin rashes were
present. AST and ALT levels were elevated to 109 IU/L
and 75 IU/L, respectively. The total bilirubin, alkaline
phosphatase, and INR were normal. A liver-protocol CT
revealed a 2.4 cm, low-density lesion at the previous surgi-
cal site, which was thought to be nonspecific. However,
given her recurrent symptoms, she was empirically treated
with a six-week course of ciprofloxacin 500 mg twice daily.
At a subsequent clinic visit in September of 2010, she
reported improvement in her abdominal pain. However,
the AST and ALT activities had risen to 139 IU/L and 195
IU/L, respectively. A transjugular liver biopsy demon-
strated small, scattered, non-caseating granulomas with a
background of micro- and macrovesicular steatosis. A
sample from the biopsy was sent to the University of
Washington for PCR analysis. Using conventional PCR
conditions and primers targeting the ribC gene (5’-
GATATCGGTTGTGTTGAAGA-3’,5 ’-AATAAAAGG-
TATAAAACGCT-3’) [17], a 393 bp PCR product specific
for B. henselae was amplified from the biopsy material. In
order to determine whether the patient was bacteremic,
venous blood samples were sent to the Intracellular Patho-
gens Research Laboratory (IPRL), Center for Comparative
Medicine and Translational Research, College of Veterin-
ary Medicine, North Carolina State University. Using a
previous described diagnostic platform [13,14], conven-
tional PCR targeting the 16S-23S intergenic spacer (ITS)
region was performed on DNA extracted from blood,
serum, and Bartonella alpha Proteobacteria growth med-
ium (BAPGM)enrichment blood cultures. No amplifica-
tion products were obtained from pre-enrichment blood
and serum samples obtained on three sequential days. In
contrast, a target band was obtained from one of three
post-enrichment blood cultures. DNA sequencing of the
amplicon was diagnostic for the ITS region of the SA2
Figure 4 Repeat abdominal CT after initial hepatic resection.
Several new, low-attenuation lesions are present in the right hepatic
lobe. Similar, smaller lesions were present in the left hepatic lobe
(not shown).
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teremia. The patient’s serum tested negative for antibodies
against B. henselae, B. koehlerae,o rBartonella vinsonii
subsp. berkhoffii genotypes I, II or III antigens [14]. Subse-
quently, using 16S-23S ITS primers, B. henselae DNA
(SA2 strain by DNA sequencing) was amplified and
sequenced from paraffin blocks containing material from
the initial liver resection (January 2009) and from the fol-
low-up biopsy obtained in September of 2010 (Figure 5).
These data demonstrated the presence of the SA2 B. hen-
selae strain in the patient’s liver throughout her course.
Immunohistochemical staining for B. henselae using a
recently described B. henselae monoclonal antibody assay
[18] showed rare coccobacilli with positive staining and
appropriate morphology for B. henselae, however, clusters
of organisms were not visualized (data not shown).
Conclusions
Our case illustrates the unique challenges of establishing
and treating B. henselae-induced granulomatous
hepatitis.
With regard to the establishment of the diagnosis,
many of the typical clinical and laboratory features of
CSD were absent. Similar to several case reports in the
literature, our patient presented with atypical and non-
specific constitutional symptoms [19]. Steiner silver
stains of infected liver tissue and immunohistochemical
assays did not reveal the culprit organism, and serologic
tests failed to detect B. henselae-specific antibodies. A
high degree of clinical suspicion, persistent attempts to
establish a specific diagnosis, and the use of optimized
enrichment cultures and PCR amplification were ulti-
mately required to establish the diagnosis in our patient.
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Figure 5 PCR results targeting the Bartonella 16S-23S rRNA intergenic spacer region using primers 325-1000 and primers 425-1100
(top row) and Bartonella koehlerae specific primers (bottom row). With primers 325-1000, amplicons were obtained in lanes 1-3 from the
resected liver lobe (pre-antibiotic treatment) but not in Lanes 4-5 (post-treatment liver biopsy). With primers 425-1000, single amplicons were
obtained in the pre- (Lane 2) and post-treatment (Lane 5) liver samples. By DNA sequencing, all amplicons corresponded to a 16S-23S strain of
B. henselae. No amplicons were obtained with the B. koehlerae primer set. RC = DNA extraction control, lane, BH = B. henselae (Houston I strain),
PO = PCR negative control, M = Kb DNA ladder.
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and performed at three different laboratories confirmed
t h ep r e s e n c eo fB. henselae at multiple time points in
the patient’s liver and serum, suggesting that this bacter-
ium was the likely causative agent in this case.
With respect to treatment options, our patient’s
course challenges the traditional view of CSD as an
inevitably self-limited disease. Recent guidelines have
stressed the importance of prolonged treatment and
antibiotic combination therapy in subgroups of patients
with CSD, including individuals with HIV infection,
bacillary angiomatosis, peliosis hepatis, retinitis, chronic
bacteremia, endocarditis, chronic lymphadenopathy and
neurological disorders [20]. However, prospective studies
validating these recommendations are lacking.
In vitro testing has demonstrated sensitivity of B. hen-
selae strains to a wide spectrum of antibiotics including
beta-lactams, macrolides, cephalosporins, aminoglyco-
sides, flouroquinolones, doxycycline and rifampin [21].
However, most of these agents are bacteriostatic and fail
to eliminate the bacterium when used as monotherapy.
In the only prospective, double-blind, placebo-controlled
study on immunocompetent patients with CSD [22], azi-
thromycin monotherapy resulted in improved lymphade-
nopathy but did not prevent dissemination or infectious
complications. This disappointing result may have been
due to the development of azithromycin resistance by B.
henselae [23]. Recurrent bacteremia has been described
in several reports [24], even after a prolonged antibiotic
course.
Our review of the published literature identified a
small number of retrospective studies using antibiotic
combination therapy: Arisoy and colleagues demon-
strated the efficacy of rifampin and gentamycin in a
small cohort of pediatric patients [25]. In a single case
report, the triple combination of doxycycline, erythro-
mycin and azithromycin cleared B. henselae-induced,
post liver-transplant granulomatous hepatitis [26,27]. A
combination of doxycycline (100 mg twice daily) and
rifampin (300 mg twice daily) was used successfully to
treat B. henselae retinitis [28]. Prednisone has been sug-
gested as adjunctive therapy in patients with antibiotic-
refractory hepatic bartonello s i s .H o w e v e r ,i m m u n o s u p -
pression should be used with caution, as it might contri-
bute to the development of Bartonella endocarditis
[29,30].
Our patient was initially treated with surgical resec-
tion, reminiscent of a previous case report by Murano
in which a giant, B. henselae-induced granuloma in a
10-year old child required a partial hepatectomy [31].
T h i sw a sf o l l o w e db ym u l t i p l ec o u r s e so fe m p i r i ca n t i -
biotic therapy, including piperacillin/tazobactam, azi-
thromycin, clarithromycin, and ciprofloxacin. None of
these treatments eradicated the infection. Following the
establishment of B. henselae bacteremia and the demon-
stration that B. henselae genetic material was present in
the patient’s liver throughout the course of her disease,
we opted to treat the patient with an 8-week course of
rifampin (300 mg bid) and doxycycline (100 mg bid).
Three months following this most recent treatment, the
patient’s liver enzymes have completely normalized for
the first time, and her constitutional symptoms have not
recurred. We are planning on a long-term follow-up
and repeat enrichment blood cultures in the future.
Informed consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
Acknowledgements
The authors wish to thank Laura Lamps at the University of Arkansas for
performing the 16S rDNA PCR, the Microbiology Department at the
University of Washington for performing the RibC PCR, Nandhakumar
Balakrishnan at North Carolina State University for performing the 16S-23S
ITS PCR, and Dr. Keith Linder at North Carolina State University for the B.
henselae immunohistochemistry. We also acknowledge Dr. Jonathan Lubens
for his critical review of the manuscript.
Author details
1Department of Internal Medicine, Division of Gastroenterology, Hepatology
and Nutrition, Loyola University Medical Center, 2160 South First Avenue,
Maywood, IL 60153, USA.
2Department of Pathology, Loyola University
Medical Center, Maywood, IL 60153, USA.
3Intracellular Pathogens Research
Laboratory, Center for Comparative Medicine and Translational Research,
College of Veterinary Medicine, North Caroline State University, Raleigh, NC
27606, USA.
4Division of Infectious Diseases, Loyola University Medical
Center, Maywood, IL 60153, USA.
Authors’ contributions
TV participated in the clinical care of the patient and wrote the manuscript.
SY carried out the pathologic studies. EB participated in the planning of the
molecular studies and editing of the final manuscript. RM performed
molecular analyses including PCR and DNA sequencing. AM participated in
the initial evaluation and treatment of the patient. JP assisted in the
selection of anti-microbial therapy. CF served as the primary hepatologist
and edited the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 27 July 2011 Accepted: 23 January 2012
Published: 23 January 2012
References
1. Bergmans AM, Groothedde JW, Schellekens JF, et al: Etiology of cat scratch
disease: comparison of polymerase chain reaction detection of
Bartonella (formely Rochalimaea) and Afipia felis DNA with serology and
skin tests. J Infect Dis 1995, 171:916-923.
2. Hansmann Y, DeMartino S, Piemont Y, et al: Diagnosis of cat scratch
disease with detection of Bartonella henseale by PCR: a study of patients
with lymph node enlargements. J Clin Microbiol 2005, 43:3800-3806.
3. Lamps LW: Hepatic Granulomas with Emphasis on Infectious Causes. Adv
Anat Pathol 2008, 15:309-318.
4. Mortele KJ, Segatto E, Ros PR: The infected liver: radiologic-pathologic
correlation. Radiographics 2004, 24:937-955.
VanderHeyden et al. BMC Infectious Diseases 2012, 12:17
http://www.biomedcentral.com/1471-2334/12/17
Page 6 of 75. Dangman BC, Albanese BA, Kacica MA, et al: Cat scratch disease in two
children presenting with fever of unknown origin: imaging features and
association with a new causative agent, Rochalimaea henselae. Pediatrics
1995, 95:767-771.
6. Drebber U, Kasper HU, Ratering J, et al: Hepatic granulomas: histological
and molecular pathological approach to different diagnosis: a study of
442 cases. Liver Int ISSN 2008, 1478:828-834.
7. Regnery RL, Olson JG, Perkins BA, Bibb W: Serological response to
“Rochalimaea henselae“ antigen in suspected cases of cat-scratch
disease. Lancet 1992, 339:1443-1445.
8. Dupon M, Savin De Larclause AM, Brouqui P, et al: Evaluation of
serological response to Bartonella henselae, Bartonella quintana and
Afipia felis antigens in 64 patients with suspected cat-scratch disease.
Scand J Infect Dis 1996, 28:361-366.
9. Caponetti GC, Pantanowitz L, Marconi S, et al: Evaluation of
immunohistochemistry in identifying Bartonella henselae in cat-scratch
disease. Am J Clin Pathol 2009, 131:250-256.
10. Adivor B, Kletter Y, Abulafia S, et al: Molecular diagnosis of cat scratch
disease: a two-step approach. J Clin Microbiol 1997, 35:1924-1930.
11. Anderson B, Sims K, Regnery R, et al: Detection of Rochalimaea henselae
DNA in specimens from cat scratch disease patients by PCR. J Clin
Microbiol 1994, 32:942-948.
12. La Scola B, Raoult D: Serological cross-reactions between Bartonella
quintana, Bartonella henselae, and Coxiella burnetti. J Clin Microbiol 1996,
34:2270-2274.
13. Breitschwerdt EB, Maggi RG, Lantos PM, et al: Bartonella vinsonii subsp.
berkhoffii and Bartonella henselae in a father and daughter with
neurological disease. Parasites and Vectors 2010, 3:29.
14. Breitschwerdt EB, Maggi RG, Sigmon B, et al: Isolation of Bartonella
quintana from a Woman and a Cat following Putative Bite Transmission.
J Clin Microbiol 2007, 45:270-272.
15. Anderson B, Sims K, Regnery R, et al: Detection of Rochalimaea henselae
DNA in specimens from cat scratch disease patients by PCR. J Clin
Microbiol 1994, 32:942-948.
16. Scott MA, McCurley TL, Vnencak-Jones CL, et al: Cat scratch disease:
detection of Bartonella henselae DNA in archival biopsies from patients
with clinically, serologically, and histologically defined disease. Am J
Pathol 1996, 149:2161-2167.
17. Bereswill S, Hinkelmann S, Kist M, et al: Molecular analysis of riboflavin
synthesis genes in Bartonella henselae and use of the ribC gene for
differentiation of Bartonella species by PCR. J Clin Microb 1999,
37:3159-3166.
18. Varanat M, Broadhurst J, Linder K, Maggi M, Breitschwerdt E: Identification
of Bartonella henselae in 2 Cats With Pyogranulomatous Myocarditis and
Diaphragmatic Myositis. Vet Pathol 2011.
19. Maman E, Bickels J, Ephros M, et al: Musculoskeletal manifestations of cat
scratch disease. Clin Infect Dis 2007, 45:1921-1933.
20. Rolain JM, Brouqui P, Koehler JE, et al: Recommendations for treatment of
human infections caused by Bartonella species; Minireview. Antimicrobiol
Agents Chemother 2004, 48:1921-1933.
21. Dorbecker C, Sander A, Oberle K, et al: In vitro susceptibility of Bartonella
species to 17 antimicrobial compounds: comparison of Etest and agar
dilution. J Antimicrob Chemother 2006, 58:784-788.
22. Bass JW, Freitas BC, Freitas AC, et al: Prospective randomized double blind
placebo-controlled evaluation of azithromycin for treatment of cat-
scratch disease. Pediatr Infect Dis J 1998, 17:447-452.
23. Biswas S, Maggi RG, Papich MG, et al: Comparative activity of
pradofloxacin, enrofloxacin and azithromycin against Bartonella henselae
isolates derived from cats and a human. J Clin Microbiol 2010, 48:617-618.
24. Sykes JE, Lindsay LL, Maggi RG, et al: Human coinfection with Bartonella
henselae and two hemotropic mycoplasma variants resembling
Mycoplasma ovis. J Clin Microbiol 2010, 48:3782-3785.
25. Arisoy ES, Correa AG, Wagner ML, et al: Hepatosplenic cat-scratch disease
in children: selected clinical features and treatment. Clin Infect Dis 1999,
28:778-784.
26. Bonatti H, Mendez J, Guerrero I, et al: Disseminated Bartonella infection
following liver transplantation. Transpl Int 2006, 19:683-687.
27. Thudi KR, Kreikemeier JT, Phillips NJ, et al: Cat scratch disease causing
hepatic masses after liver transplant. Liver Int 2007, 27:145-148.
28. Reed JB, Scale DK, Wong MT, et al: Bartonella henselae neuroretinitis in
cat scratch disease. Diagnosis, management, and sequelae. Ophthalmol
1998, 105(3):459-466.
29. Turner JW, Pien BC, Ardoin SA, et al: A man with chest pain and
glomerulonephritis. Lancet 2005, 365:2062.
30. Vikram HR, Bacani AK, DeValeria PA, et al: Bivalvular Bartonella henselae
prosthetic valve endocarditis. J Clin Microbiol 2007, 45:4081-4084.
31. Murano I, Yoshii H, Kurashige H, et al: Giant hepatic granuloma caused by
Bartonella henselae. Pediatr Infect Dis J 2001, 20:319-320.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/12/17/prepub
doi:10.1186/1471-2334-12-17
Cite this article as: VanderHeyden et al.: Granulomatous hepatitis due to
Bartonella henselae infection in an immunocompetent patient. BMC
Infectious Diseases 2012 12:17.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
VanderHeyden et al. BMC Infectious Diseases 2012, 12:17
http://www.biomedcentral.com/1471-2334/12/17
Page 7 of 7